L,D-转肽酶LdtMt2-厄他培南加合物的新状态Ⅰ-plus结构

具有多重耐药性和广泛耐药性的结核分枝杆菌菌株正在全球范围内传播,因此,迫切需要新的抗结核药物。结核分枝杆菌的L,D-转肽酶LdtMt2直接参与肽聚糖的形成,细菌毒性和β-内酰胺抗性。该酶是潜在的抗结核靶标,可以被碳青霉烯类抗生素抑制,碳青霉烯类抗生素是FDA批准的用于治疗肺结核的药物。据报道,LdtMt2与碳青霉烯类抗生素（如厄他培南,亚胺培南和美洛培南）相互作用时,存在两种不同的中间状态,即状态I和II。状态I被认为是初始加合物形成状态,而状态II被认为是稳定的蛋白质-配体相互作用状态,并伴有碳青霉烯类抗生素和蛋白质的局部构象排列。本文中,我们报告了一个LdMt2-ertapenem新中间状态I-plus,具有与状态II相同的碳青霉烯类抗生素构象和与状态I相似的局部蛋白质构象。该新状态是从状态I转变为状态II的中间状态,构象变化发生在厄他培南分子而不是蛋白质。我们的工作有助于阐明碳青霉烯类抗生素对LdtMt2的作用后发生的变化,并与其他报道的中间状态一起揭示L,D-转肽酶如何与碳青霉烯类抗生素相互作用。     

西双版纳入侵长足捷蚁与土著黄猄蚁的种间竞争

【目的】入侵物种能够通过竞争影响本地物种的种群,从而影响入侵地的生物多样性。长足光捷蚁Anoplolepis gracilipes是全球最具破坏力的入侵蚂蚁之一。本研究旨在明确西双版纳地区入侵长足捷蚁与土著优势种蚂蚁黄猄蚁Oecophylla smaragdina之间的竞争关系。【方法】通过野外调查和室内控制试验相结合的方法,观察和对比分析长足捷蚁和黄猄蚁的体型大小,雾凉季和雨季的巢穴外觅食活动规律,觅食能力(搜寻食物的时间、在觅食时间内召集的最大工蚁数),打斗行为(不同打斗组合的攻击强度和死亡率)以及对饥渴的耐受性(无食物和水分供应时平均存活时间和存活率随时间的变化)。【结果】长足捷蚁工蚁体长(3.66±0.06 mm)显著小于黄猄蚁工蚁(8.27±0.16 mm)。在雾凉季时,长足捷蚁具有比黄猄蚁更长的觅食活动时间;而在雨季时,两种蚂蚁均在下午温度较高时段觅食活动的个体数量减少。苹果、蜂蜜和火腿肠3种食物作为诱饵时,长足捷蚁具有更快搜寻食物的能力,4~8 min便能找寻到食物,而黄猄蚁需要8~21 min才能找寻到食物,此外在寻找到食物后,长足捷蚁也有更快召集同伴的能力。在人工控制试验中,1头长足捷蚁和1头黄猄蚁同时存在时主要以不攻击和低强度攻击为主,而当两种蚂蚁中的任意其中一种的个体数量增加到5头时,攻击强度会显著增加,两种蚂蚁均存在种间协作行为。在饥渴状态下,两种蚂蚁工蚁的平均存活时间差异不显著,但长足捷蚁最长存活120 h,黄猄蚁最长存活96 h。【结论】在西双版纳地区,长足捷蚁相较于土著黄猄蚁具有更强的觅食的能力,雾凉季觅食活动时间更长,暗示长足捷蚁可能具有较强的温度适应能力。有必要加强对这一入侵蚂蚁的研究,并密切关注其种群在该地区的发展。     

Ghrelin Affects Gastric Cancer Progression by Activating AMPK Signaling Pathway

Biochemical Genetics - As the endogenous ligand for the GH secretagogue receptor (GHSR), Ghrelin is aberrant expressed in multiple malignant carcinoma, and involved in regulating a number of...     

基于UPLC-QTOF-MS技术分析多脂鳞伞特征性成分及体外抗肿瘤作用

多脂鳞伞是一种较为珍贵的药食用真菌。对其化学成分及体外抗肿瘤作用进行了研究。通过UPLC-QTOF-MS法、电喷雾离子源（ESI）及负离子全扫描模式测定了人工栽培多脂鳞伞的化学成分组成;体外培养HepG-2、A549、Hela及MCF-7,用不同质量浓度多脂鳞伞乙醇提物处理细胞,应用CCK-8法及流式细胞术进行细胞毒性测试,并应用流式细胞术选择HepG-2细胞系以进一步评估其对HepG-2细胞凋亡分析。结果表明：经UPLC-QTOF-MS分析,从多脂鳞伞子实体分析得到的化学成分与食药用菌成分数据库中的38种成分相吻合,其中棕榈酸与9E,12E-octadecadienoic acid含量最高,甾醇类化合物与多糖类化合物占比较高;多脂鳞伞乙醇提取物对HepG-2细胞毒性最强,其浓度为50μg/mL时凋亡率能够达到(23.71±1.59)%。多脂鳞伞具有多种功能性化学成分,并具有潜在的抗肿瘤应用价值,初步断定其抗肿瘤活性是功能性成分通过诱导细胞凋亡实现的。     

不同碳氮源对花脸香蘑胞外酶活性的影响

以花脸香蘑Lepista sordida为材料,研究其分别在9种碳源和11种氮源液体培养条件下不同阶段pH值和葡萄糖浓度的变化,以及不同碳氮源对其所分泌的木质素过氧化物酶、羧甲基纤维素酶、锰过氧化物酶和漆酶活性的影响。结果表明,pH值在不同碳源培养后期变化显著（P<0.05）,而在不同氮源培养阶段无明显变化（P>0.05）,葡萄糖浓度和菌丝量在不同碳氮源中也无显著差异（P<0.05）。不同碳源和氮源培养基对花脸香蘑木质素过氧化物酶、羧甲基纤维素酶、锰过氧化物酶和漆酶活性均具有影响（P<0.05）。木糖和米糠有利于花脸香蘑分泌羧甲基纤维素酶（P<0.05）,红糖和牛肉浸膏有利于其分泌漆酶（P<0.05）,白砂糖和豆粉有利于其分泌锰过氧化物酶（P<0.05）,木糖和尿素有利于其分泌木质素过氧化物酶（P<0.05）。本研究为选择合适培养基以提高花脸香蘑生物转化效率提供了理论基础。     

Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner during sepsis

Thrombocytopenia is independently related with increased mortality in severe septic patients. Renin-angiotensin system (RAS) is elevated in septic subjects; accumulating studies show that angiotensin II (Ang II) stimulate the intrinsic apoptosis pathway by promoting reactive oxygen species (ROS) production. However, the mechanisms underlying the relationship of platelet apoptosis and RAS system in sepsis have not been fully elucidated. The present study aimed to elucidate whether the RAS was involved in the pathogenesis of sepsis-associated thrombocytopenia and explore the underlying mechanisms. We found that elevated plasma Ang II was associated with decreased platelet count in both patients with sepsis and experimental animals exposed to lipopolysaccharide (LPS). Besides, Ang II treatment induced platelet apoptosis in a concentration-dependent manner in primary isolated platelets, which was blocked by angiotensin II type 1 receptor (AT1R) antagonist losartan, but not by angiotensin II type 2 receptor (AT2R) antagonist PD123319. Moreover, inhibiting AT1R by losartan attenuated LPS-induced platelet apoptosis and alleviated sepsis-associated thrombocytopenia. Furthermore, Ang II treatment induced oxidative stress level in a concentration-dependent manner in primary isolated platelets, which was partially reversed by the AT1R antagonist losartan. The present study demonstrated that elevated Ang II directly stimulated platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner in sepsis-associated thrombocytopenia. The results would helpful for understanding the role of RAS system in sepsis-associated thrombocytopenia.     

脐带血造血干/祖细胞体外分化为不同阶段红系祖细胞的动力学观察

目的:探讨体外培养脐带血单个核细胞定向诱导分化为不同阶段红系祖细胞的动力学变化情况。方法:用0.5%甲基纤维素沉降脐带血红细胞及人淋巴细胞分离液密度梯度离心法得到单个核细胞,在含EPO、SCF、IGF-1等细胞因子的无血清培养体系中诱导其定向分化为红系祖细胞,观察细胞增殖、存活率、细胞集落形成情况,并检测不同阶段细胞红系特异性表面标志CD71和CD235a的表达。结果:随着培养时间的延长,细胞数逐渐增多,14 d细胞可扩增140倍左右,收集诱导后的细胞进行瑞氏吉姆萨染色,可见大量红系祖细胞,诱导后的细胞集落形成能力强,形成的克隆大部分为红系集落。诱导过程中,14 d前CD71、CD235a的表达逐渐增高。按细胞表面标志表达的不同可将诱导的细胞分为4群,分别对应红系祖细胞的不同阶段;随着诱导天数的增加,各时间点细胞对应的早期红系祖细胞群(P2、P3)比例逐渐下降,中晚期红系祖细胞群(P4、P5)的比例逐渐上升。结论:无血清培养基添加细胞因子组合的红系诱导培养体系可较好地诱导扩增红系祖细胞,流式分选可获得相对均一而处于不同分化阶段的红系祖细胞群体。获得了红系祖细胞体外分化的动力学数据,为今后进一步优化红系诱导分化体系获得均一的红系祖细胞奠定了基础,并对未来利用干细胞制备均一的红系祖细胞应用于临床治疗有一定的指导作用。     

The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis

Background

BRAF mutation has been investigated as a prognostic factor in metastatic colorectal cancer (mCRC) undergoing anti-EGFR monoclonal antibodies (moAbs), but current results are still inconclusive. The aim of this meta-analysis was to evaluate the relationship between BRAF mutation status and the prognosis of mCRC patients treated with moAbs.

Methods

Eligible studies were identified by systematically searching Pubmed, the Cochrane Library, Web of Knowledge, and OVID. Risk ratio (RR) for overall response rate (ORR), Hazard ratios (HRs) for Progression free survival (PFS) and Overall survival (OS) were extracted or calculated. Prespecified subgroup analyses were conducted in KRAS wild-type and in different study types. The source of between-trial variation was explored by sensitivity analyses. Quality assessment was conducted by the Hayden’s criteria.

Results

A total of twenty one trials including 5229 patients were identified for the meta-analysis. 343 patients displayed BRAF mutations of 4616 (7.4%) patients with known BRAF status. Patients with BRAF wild-type (WT) showed decreased risks of progression and death with an improved PFS(HR 0.38, 95% confidence intervals 0.29–0.51) and an improved OS (HR 0.35 [0.29–0.42]), compared to BRAF mutant. In KRAS WT population, there were even larger PFS benefit (HR 0.29[0.19,0.43]) and larger OS benefit (HR 0.26 [0.20,0.35]) in BRAF WT. A response benefit for BRAF WT was observed (RR 0.31[0.18,0.53]) in KRAS WT patients, but not observed in unselected patients (RR 0.76 [0.43–1.33]). The results were consistent in the subgroup analysis of different study types. Heterogeneity between trials decreased in the subgroup and explained by sensitivity analysis. No publication bias of ORR, PFS and OS were detected.

Conclusions

The results indicate that BRAF mutant is a predictive biomarker for poor prognosis in mCRC patients undergoing anti-EGFR MoAbs therapy, especially in KRAS WT patients. Additional large prospective trials are required to confirm the predictive role of BRAF status.     

Splicing Factor Transformer-2β (Tra2β) Regulates the Expression of Regulator of G Protein Signaling 4 (RGS4) Gene and Is Induced by Morphine

Regulator of G protein signaling 4 (RGS4) is a critical modulator of G protein-coupled receptor (GPCR)-mediated signaling and plays important roles in many neural process and diseases. Particularly, drug-induced alteration in RGS4 protein levels is associated with acute and chronic effects of drugs of abuse. However, the precise mechanism underlying the regulation of RGS4 expression is largely unknown. Here, we demonstrated that the expression of RGS4 gene was subject to regulation by alternative splicing of the exon 6. Transformer-2β (Tra2β), an important splicing factor, bound to RGS4 mRNA and increased the relative level of RGS4-1 mRNA isoform by enhancing the inclusion of exon 6. Meanwhile, Tra2β increased the expression of full-length RGS4 protein. In rat brain, Tra2β was co-localized with RGS4 in multiple opioid action-related brain regions. In addition, the acute and chronic morphine treatment induced alteration in the expression level of Tra2β in rat locus coerulus (LC) in parallel to that of RGS4 proteins. It suggests that induction of this splicing factor may contribute to the change of RGS4 level elicited by morphine. Taken together, the results provide the evidence demonstrating the function of Tra2β as a new mediator in opioid-induced signaling pathway via regulating RGS4 expression.